Anthropic CEO Dario Amodei reiterated on X on August 16 that AI will cure most human diseases within five to ten years, a prediction he first made in his October 2024 essay 'Machines of Loving Grace.'…
ICON plc has agreed a multi-year collaboration with Anthropic to deploy its Claude AI across clinical trial processes, targeting operational bottlenecks rather than scientific discovery. Pip White, An…
Anthropic launched Claude Science, an AI-powered research platform integrating over 60 scientific tools for drug discovery, focusing on neglected and rare diseases that big pharma ignores. The company…
Anthropic launched an AI drug discovery program on May 5, 2025, offering free API credits to researchers in biology and life sciences. The company later launched Claude for Life Sciences and acquired …
Nobel laureate John Jumper, who won the 2024 Nobel Prize in Chemistry for creating AlphaFold, is leaving Google DeepMind after nearly nine years to join Anthropic. The departure follows Gemini co-lead…